This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: University of Michigan. Active years: 2014-2016.
Company Filing History:
Years Active: 2014-2016
Title: Michael Swanson: Innovator in Antiviral and Antimicrobial Research
Introduction
Michael Swanson is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of chemical compounds, particularly in the development of antiviral and antimicrobial lectins. With a total of 2 patents, his work has implications for therapeutic and research applications.
Latest Patents
Michael Swanson's latest patents focus on lectins and their various uses. The first patent describes chemical compounds and methods for their discovery, emphasizing their therapeutic and research applications. Specifically, it provides antiviral and antimicrobial lectin compounds, including BanLec, which is isolated from bananas. This invention highlights the compounds' low mitogenicity and pro-inflammatory activity while maintaining anti-HIV-1 activity.
Career Highlights
Michael Swanson is affiliated with the University of Michigan, where he conducts his research. His work has garnered attention for its innovative approach to addressing viral infections and antimicrobial resistance.
Collaborations
Some of his notable coworkers include David M Markovitz and Irwin J Goldstein, who have contributed to his research endeavors.
Conclusion
Michael Swanson's contributions to the field of antiviral and antimicrobial research through his patents reflect his commitment to innovation and scientific advancement. His work continues to pave the way for new therapeutic options in combating viral infections.